Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

National Institute of Allergy and Infectious Diseases director Anthony Fauci at the White House in January. Photo: Alex Wong/Getty Images

NIAID director Anthony Fauci said during a White House briefing Wednesday that 20,000 pregnant women have been vaccinated against COVID-19 without complications.

Why it matters: The new figure comes weeks after the World Health Organization altered its guidance for pregnant women and inoculation to say those at high risk of exposure to COVID-19, or who have comorbidities that increase their risk of severe disease, may be vaccinated, in line with CDC guidance.

Go deeper

Knowing someone who's been vaccinated helps reduce hesitancy

Photo: Angus Mordant/Bloomberg via Getty Images

Knowing someone who has been vaccinated, and seeing that the vaccine does not produce any significant adverse effects, is emerging as the leading reason people are willing to get vaccinated themselves. 

Why it matters: This means vaccine hesitancy should diminish naturally as more people are vaccinated.

Feb 10, 2021 - Health

CDC asks public to consider wearing 2 masks or adjusting tighter fit

Illustration: Sarah Grillo/Axios

Wearing two face masks or adjusting a mask to fit more snuggly can better help protect against COVID-19 and its highly transmissible variants, the Centers for Disease Control and Prevention advised in new guidance out Wednesday.

Why it matters: Modeling shows the B.1.1.7 variant from the U.K. could become the dominant strain in the U.S. by the end of March, said Anthony Fauci, President Biden's chief medical adviser, on Wednesday.

Feb 10, 2021 - Health

FDA grants emergency use authorization for Eli Lilly COVID antibody drug

Photo: Igor Golovniov/SOPA Images/LightRocket via Getty Images

The FDA announced Tuesday it has issued an emergency use authorization for a new combination antibody drug from Eli Lilly that can treat mild to moderate COVID-19.

Why it matters: The treatment contains bamlanivimab and etesevimab which, administered together, can reduce the risk of hospitalizations and death by 70%, per an FDA statement. It can be used on patients at high risk of developing severe illnesses.